Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of chemotherapy-induced ovarian failure with goserelin in young hormone-insensitive breast cancer
2004-003980-62Phase 2Completed
- Sponsor
- GBG Forschungs
- Start
- May 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of goserelin in breast cancer (2 arms), sponsored by GBG Forschungs. Primary endpoint: Normal ovarian function at 6 months after chemotherapy. Started May 2005; status: completed.
02
Drugs
goserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-003980-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003980-62.